The Effect of IL-22 and IL-28 in Induction of Type 1 Regulatory T (Tr1) Cells


Cytokines have been introduced as critical inducers in the development of Th subpopulations.Cytokines like IL-10 are involved in inducing regulatory T cells such as Type 1 regulatory T (Tr1) cells cells. IL-22 is a member of IL-10 family of cytokines, and IL-28A is a member of IFN-γ family. In this study, cord blood mononuclear cells (CBMC) from normal healthy individuals were isolated by Ficoll and then naïve T cells were purified by CD4+CD25+ Regulatory T cell Isolation kit. The effect of these two cytokines on production of IL-5, TGF-β, IL-10, IL-4 and IFN-γ cytokines from cord blood T cells was investigated to identify Tr1 cells as well as Th1 and Th2 polarization. Flow cytometric analysis showed that IL-28A and IL-22 were not effective in expression of IL-5 and TGF-β either alone or in synergy, but in view of IL-10, IL-4 and IFN-γ, the results showed that IL-22 increased IL-10 and IL-4 but had a decreasing effect on IFN-γ. The results showed that IL-28A was not effective in increasing or decreasing the level of IL-10, IL-4 and IFN-γ. Therefore, according to these results, IL-22 and IL-28A were not effective in inducing Tr1 cells.

1. Battaglia M, Gregori S, Bacchetta R, Roncarolo MG. Tr1 cells: from discovery to their clinical application. Semin Immunol 2006; 18(2):120-7.

2. Kwon BS, Wang S, Udagawa N, Haridas V, Lee ZH, Kim KK, et al. TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB J 1998; 12(10):845-54.

3. Ye F, Yan S, Xu L, Jiang Z, Liu N, Xiong S, et al. Tr1 regulatory T cells induced by ConA pretreatment prevent mice from ConA-induced hepatitis. Immunol Lett 2009;122(2):198-207.

4. D'Elios M, Del Prete G. Th1/Th2 balance in human disease. Transplant Proc 1998; 30(5):2373-7 .

5. Nagem RA, Colau D, Dumoutier L, Renauld JC, Ogata C,Polikarpov I. Crystal structure of recombinant human Interleukin-22. Structure 2002; 10(8):1051-62.

6. Bleicher L, de Moura PR, Watanabe L, Colau D, Dumoutier L, Renauld JC, et al. Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism. FEBS Lett 2008; 582(20):2985-92.

7. Aggarwal S, Xie MH, Maruoka M, Foster J, Gurney AL.Acinar cells of the pancreas are a target of interleukin-22. J Interferon Cytokine Res 2001; 21(12):1047-53.

8. Gurney AL. IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int Immunopharmacol 2004; 4(5):669-77.

9. Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000; 275(40):31335-9.

10. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 2006; 80(9):4501-9.

11. Meager A, Visvalingam K, Dilger P, Bryan D, Wadhwa M. Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 2005;31(2):109-18.

12. Commins S, Steinke JW, Borish L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 2008;121(5):1108-11.

13. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003; 4(1):63-8.

14. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005; 6(12):1219-27.

15. Lu L, Li G, Rao J, Pu L, Yu Y, Wang X, et al. In vitro induced CD4(+)CD25(+)Foxp3(+) Tregs attenuate hepatic ischemia-reperfusion injury. Int Immunopharmacol 2009; 9(5):549-52.

16. Verhasselt V, Vosters O, Beuneu C, et al. Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells. Eur J Immunol 2004;34(3):762-72.

17. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004; 21(2):241-54.

18. Steinke JW, Borish L. Cytokines and chemokines. J Allergy Clin Immunol 2006; 117:441-5.

19. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A,

Shen M, Shah NK, et al. IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4(1):69-77.

20. McRae BL, Semnani RT, Hayes MP, van Seventer GA.Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol 1998;160(9):4298-304.

21. Roncarolo MG, Levings MK. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 2000; 12(6):676-83.

22. Martin-Saavedra FM ,Gonzalez-Garcia C, Bravo B, Ballester S. Beta interferon restricts the inflammatory potential of CD4+ cells through the boost of the Th2 phenotype, the inhibition of Th17 response and the prevalence of naturally occurring T regulatory cells. Mol Immunol 2008; 45(15):4008-19.

23. Levings MK, Roncarolo MG. T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. J Allergy Clin Immunol 2000; 106(1 Pt2):S109-112.

24. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001; 166(9):5530-9.

25. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen- specific T-cell responses and prevents colitis. Nature 1997; 389(6652):737-42.

26. Pot C ,Apetoh L, Awasthi A, Kuchroo VK. Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27. Semin Immunol 2011; 23(6):438-45.

27. Wang H, Meng R, Li Z, Yang B, Liu Y, Huang F, et al.IL-27 induces the differentiation of Tr1-like cells from human naive CD4+ T cells via the phosphorylation of STAT1 and STAT3. Immunol Lett 2011; 136(1):21-8.

28. Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421(6921):388-92 .

29. Oral HB, Kotenko SV ,Yilmaz M, Mani O, Zumkehr J, Blaser K, et al. Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol 2006; 36(2):380-8.

30. Pillai V, Ortega SB, Wang CK, Karandikar NJ. Transient regulatory T-cells: A state attained by all activated human T-cells. Clin Immunol 2007; 123(1):18-29.

31. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203(7):1701-11 .

32. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330-6.

33. Shevach EM. Regulatory/suppressor T cells in health and disease. Arthritis Rheum 2004; 50(9):2721-4 .

34. Carrier Y, Yuan J, Kuchroo VK, Weiner HL. Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity. J Immunol 2007; 178(1):172-8.

35. Satoguina JS, Adjobimey T, Arndts K, Hoch J, Oldenburg J, Layland LE, et al. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. Eur J Immunol 2008; 38(11):3101-13.

36. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001; 182:68-79.

37. Arasteh J, Pourpak Z, Ebtekar M, et al. Evaluation of the effect of IL-22 on human cord blood CD4+ T cells. Iran J Allergy Asthma Immunol 2010; 9(2):59-67.

38. Arasteh J, Ebtekar M, Pourpak Z, Pourfatollah AA, Hassan ZM, Farahmandian T. The effect of IL-28A on human cord blood CD4+ T cells. Immunopharmacol Immunotoxicol 2010; 32(2):339-47.

IssueVol 14, No 2 (2015) QRcode
Cord blood IL-22 IL-28A Polarization Tr1 cells

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Arasteh J, Ebtekar M, Pourpak Z, Pourfatollah AA, Hassan ZM, Kardar GA, Zare A, Saghafi S, Tabar Molla Hassan A. The Effect of IL-22 and IL-28 in Induction of Type 1 Regulatory T (Tr1) Cells. Iran J Allergy Asthma Immunol. 1;14(2):158-167.